PDF(2092 KB)
PDF(2092 KB)
PDF(2092 KB)
卡瑞利珠单抗联合化疗对比化疗在晚期鳞状非小细胞肺癌一线治疗中的成本效果分析
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Cost-effectiveness of camrelizumab combined with chemotherapy vs.chemotherapy alone as first-line treatment for advanced squamous non-small cell lung cancer
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
